Table 1.

Legend: BMI = Body Mass Index; BSQ-SF = Body Shape Questionnaire-Short Form; BCS = Body Comparison Scale; DEBQ-R = Dutch Eating Behavior Questionnaire Restraint; EDI-B = Eating Disorder Inventory for Bulimia; SATAQ-3 = Sociocultural Attitudes Towards Appearance Scale-3; BDI-SF = Beck Depression Inventory Short Form; EDE-Q = Eating Disorder Examination Questionnaire; SEED = Short Evaluation of Eating Disorders; STAI = State-Trait Anxiety Inventory; EQ-5D-5L = EuroQoL-EQ-5L; EDE = Eating Disorder Examination; RSE = Rosenberg Self Esteem Scale; MINI-Kid = Mini International Neuropsychiatric Interview for Children and Adolescents; WCS = Weight Concerns Scale; MPS-F = Frost Multidimensional Perfectionism Scale; PMI = Parent Motivation Inventory.

Authors	Year	Title	Nation	Type of Study	Sample	Measures	Follow Up	Results
Heinicke, B. E., Paxton, S. J., McLean, S. A., and Wertheim, E. H.	2007	Internet-delivered targeted group intervention for body dissatisfaction and disordered eating in adolescent girls: a randomized controlled trial.	Australia	Randomized Controlled Trial	73	BMI BSQ-SF DEBQ-R EDI-B SATAQ BDI-SF	2 months 6 months	Significant improvements in measures of body dissatisfaction and symptoms of disordered eating (T2) in the intervention group undergoing CBT-like online sessions. These results were also maintained in the follow-up at 2 and 6 months.
Anastasiadou, D., Folkvord, F., Brugnera, A., Cañas Vinader, L., SerranoTroncoso, E., Carretero Jardí, C., Linares Bertolin, R., Muñoz Rodríguez, R., Martínez Nuñez, B., Graell Berna, M., Torralbas-Ortega, J., Torrent-Solà, L., Puntí-Vidal, J., Carrera Ferrer, M., Muñoz Domenjó, A., Diaz Marsa, M., Gunnard, K., Cusido, J., Arcal Cunillera, J., & Lupiañez-Villanueva, F	2020	An mHealth intervention for the treatment of patients with an eating disorder: A multicenter randomized controlled trial.	Spain	Randomizes controlled trial	106	EDE-Q SEED BDI-II STAI EQ-5D-5L	NO	Significant reductions in primary and secondary outcomes were observed for participants in both groups, with no differences between the experimental and control groups, demonstrating that the combined intervention between CBT and smartphone apps does not provide further improvements in symptoms.
Anderson, K. E., Byrne, C. E., Crosby, R. D., and Le Grange, D.	2017	Utilizing Telehealth to deliver family-based treatment for adolescent anorexia nervosa.	USA	Clinical trial	10	BMI EDE BDI RSE MINI-kid	6 months	The percentage of mBMI improved significantly from basaline to the end of treatment, and from baseline to FU, with medium-large effect sizes. Reduction in secondary symptoms (depression).
Jacobi, C., Hütter, K., Völker, U., Möbius, K., Richter, R., Trockel, M., Jones Bell, M., Lock, J., & Taylor, C. B.	2018	Efficacy of a Parent-Based, Indicated Prevention for Anorexia Nervosa: Randomized Controlled Trial	Germany	Randomized controlled trial	66 Families with high risk’s daughters for AN.	WCS EDI-2 MPS-F EDE PMI	6 months 12 months	The girls in the intervention group gained significantly more weight, although the size of the effect falls within the medium-small range. Parental participation in prevention intervention was very low
Yaffa S. Adi E Itai P. Marit J. Doron G. Daniel S.	2021	Treatment of eating disorders in adolescents during the COVID-19 pandemic: a case series	Israel	Case report	4 patients with ED		NO	The use of multidisciplinary interurban telemedicine treatment resulted in an improvement in the condition in three of the four adolescents living in well-organized families, only one teenager showed no improvement.
Wood M., M.S.H.P MD., White K., M.P.H MD., Peebles R., Pickel MD J., Alausa M., Mehringer J., Dowshen N., M.S.H.P. MD.	2020	Outcomes of a Rapid Adolescent Telehealth Scale-Up During the COVID-19 Pandemic	USA	Clinica Trial	392		No	In 331 unique patients, with an 82% appointment completion rate. Video visits were conducted for eating disorders (39%), contraception/menstrual disorders (22%), gender-affirming care (17%), general adolescent medicine (15%), HIV treatment (6%), and substance abuse (1%).